Argentine pharmaceuticals faced contamination risks due to lax GMP standards.
["GMP compliance for pharmaceutical manufacturers", "Inspection by competent authority", "Certificate issued per WHO/ICH standards"]
Import refusal; manufacturing suspension; fines
Affected HS Codes: ["3001", "3002", "3003", "3004", "3005", "3006"]
Issuing Authority: ANMAT